What we're reading, October 25, 2016: individuals with discontinued Obamacare plans will have a special enrollment period; Arizona governor orders limits on opioid prescriptions; and the FDA aims to speed up generic drug reviews.
Individuals who are currently enrolled in an Affordable Care Act plan that will be discontinued next year when the insurer leaves the market will have extra time to get coverage. People who lost their coverage can sign up as late as December 31 and still have coverage begin on January 1 if they can attest to the situation, reported The Wall Street Journal. However, if they miss that deadline, their special enrollment period doesn’t end until March 1—they will simply have a lapse in coverage. The Obama administration expects 13.8 million individuals to select plans for 2017.
In Arizona, the governor has ordered limits on opioid prescriptions in the state’s employee insurance plan and Medicaid plan. The Washington Times reported that the order would limit the initial prescription to just 7 days. In addition, a pre-approval will no longer be needed for people with state-provided insurance to be prescribed a drug used to treat recovering addicts.
The FDA is aiming to speed up the review process for generic drugs. According to Roll Call, the agency is committing to a 10-month review, but there would be an 8-month timeline for applications that could impact access or cost. For instance, drugs that could impact public health, address a drug shortage, or introduce generic competition to the market would be eligible for the accelerated timeline.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More